Comment
doi: 10.1016/S0140-6736(21)01385-4.
Cardiovascular safety of febuxostat
Affiliations
- PMID: 34509227
- DOI: 10.1016/S0140-6736(21)01385-4
Item in Clipboard
Comment
Cardiovascular safety of febuxostat
Lancet.
.
No abstract available
Conflict of interest statement
I declare no competing interests.
Comment in
-
Cardiovascular safety of febuxostat - Authors' reply.Lancet. 2021 Sep 11;398(10304):955-956. doi: 10.1016/S0140-6736(21)01383-0. Lancet. 2021. PMID: 34509228 No abstract available.
Comment on
-
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial.Lancet. 2020 Nov 28;396(10264):1745-1757. doi: 10.1016/S0140-6736(20)32234-0. Epub 2020 Nov 9. Lancet. 2020. PMID: 33181081 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
